BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $90,850,000 | 40.87% |
Deep Track Capital, LP | 1,250,000 | $48,388,000 | 3.18% |
HSG Holding Ltd | 796,089 | $30,817,000 | 2.84% |
Redmile Group, LLC | 1,849,887 | $71,609,000 | 2.73% |
ARK Investment Management | 8,792,064 | $309,305,000 | 1.83% |
Evolutionary Tree Capital Management, LLC | 31,893 | $1,235,000 | 1.34% |
BRANDYWINE MANAGERS, LLC | 13,067 | $506,000 | 1.24% |
Casdin Capital, LLC | 375,000 | $14,516,000 | 1.23% |
Temasek Holdings (Private) Ltd | 3,959,212 | $153,261,097 | 0.84% |
Yiheng Capital Management, L.P. | 363,800 | $14,083,000 | 0.80% |
FARALLON CAPITAL MANAGEMENT LLC | 3,472,271 | $134,412,000 | 0.73% |
Alphabet Inc. | 321,604 | $12,449,000 | 0.68% |
HighVista Strategies LLC | 20,980 | $812,000 | 0.49% |
Capital Impact Advisors, LLC | 8,931 | $346,000 | 0.32% |
Bellevue Group AG | 572,621 | $22,166,000 | 0.31% |
Baker Chad R | 27,550 | $1,067,000 | 0.30% |
Eagle Health Investments LP | 28,900 | $1,119,000 | 0.26% |
KRAEMATON INVESTMENT ADVISORS, INC | 5,515 | $213,000 | 0.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 910 | $23,500,000 | 0.24% |
Graham Capital Management, L.P. | 135,588 | $5,248,000 | 0.21% |
External links
This page lists BEAM THERAPEUTICS INC's shareholders in Q2 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.